Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EFP Biotek is a leading Portuguese biotechnology company specializing in the development and manufacture of natural, sustainable ingredients for the pharmaceutical, cosmetic, and personal care industries. The company is globally recognized for its expertise in Green Chemistry and the upcycling of agricultural by-products, particularly from olive oil production. Their core product portfolio includes high-purity squalane and squalene, which serve as essential emollients and critical components for vaccine adjuvants. Additionally, EFP Biotek offers innovative vegetable-based alternatives to traditional petroleum-derived ingredients like petrolatum and lanolin. By focusing on circular economy principles, the company provides high-performance, eco-friendly solutions to global health and beauty brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EFP Biotek.